Article
Specific KRAS amino acid substitutions and EGFR mutations predict site-specific recurrence and metastasis following non-small-cell lung cancer surgery.
British journal of cancer - 26 Jul 2016
Renaud Stéphane, Seitlinger Joseph, Falcoz Pierre-Emmanuel, Schaeffer Mickaël, Voegeli Anne-Claire, Legrain Michèle, Beau-Faller Michèle, Massard Gilbert
Abstract excerpt
BACKGROUND: We aimed to evaluate whether EGFR mutations (mEGFR) and KRAS amino acid substitutions can predict first site of recurrence or metastasis after non-small-cell lung cancer (NSCLC) surgery. METHODS: Data were reviewed from 481 patients who underwent thoracic surgery for NSCLC between 2007 and 2012. RESULTS: Patients with KRAS G12C developed significantly more bone metastases compared with the remainder...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
